CONSOLIDATED STATEMENTS OF EQUITY - USD ($)	Total	Series B1 Preferred Stock	Series B Preferred Stock	Common Stock	Common Stock Series B1 Preferred Stock	Common Stock Series B Preferred Stock	Preferred stock Series A Preferred	Preferred stock Series C Preferred	Additional Paid-In Capital	Additional Paid-In Capital Series B1 Preferred Stock	Additional Paid-In Capital Series B Preferred Stock	Retained Earnings	Non-controlling Interest
Beginning balance at Dec. 31, 2019	$ 23,102,026			$ 43,396			$ 420	$ 0	$ 81,527,351			$ (59,246,514)	$ 777,373
Beginning balance (in shares) at Dec. 31, 2019				43,395,563			419,859	0
Increase (Decrease) in Stockholders' Equity
Purchase of shares of consolidated subsidiary	(71,171)								(71,171)
Share based compensation expense	163,269								163,269
Conversion of Series B/B-1 Preferred stock to common	3,368,474			$ 2,159					3,366,315
Conversion of Series B/B-1 Preferred stock to common (in shares)				2,159,278
Adjustment of carrying amount of non-controlling interest	9,091,068								9,091,068
Dividends on Series B and B1	(344,499)											(344,499)
Accretion of discount on Series B and B1	(932,003)	$ (518,114)	$ (413,889)									(932,003)
Accretion of redeemable non-controlling interest to redemption value	(10,966,349)											(10,966,349)
Net income (loss)	2,390,251											2,788,860	(398,609)
Less: amount attributable to redeemable non-controlling interest	517,877												517,877
Ending balance at Mar. 31, 2020	26,318,943			$ 45,555			$ 420	$ 0	94,076,832			(68,700,505)	896,641
Ending balance (in shares) at Mar. 31, 2020				45,554,841			419,859	0
Beginning balance at Dec. 31, 2020	5,924,749			$ 45,555			$ 420	$ 0	94,569,674			(90,008,778)	1,317,878
Beginning balance (in shares) at Dec. 31, 2020				45,554,841			419,859	0
Increase (Decrease) in Stockholders' Equity
Exercise of options/ B1 warrants	0	2,757,957		$ 23	$ 1,080				(23)	$ 2,756,877
Exercise of options/B1 warrants (in shares)				22,992	1,079,753
Exchanges of Series B Preferred stock to common	4,747,250			$ 2,359					4,114,570			630,321
Exchanges of Series B Preferred stock to common (in shares)				2,359,494
Share based compensation expense	150,514								150,514
Conversion of Series B/B-1 Preferred stock to common		3,256,024	1,978,494		$ 2,087	$ 638				$ 3,253,937	$ 1,977,856
Conversion of Series B/B-1 Preferred stock to common (in shares)					2,087,195	638,224
Dividends on Series B and B1	(372,183)											(372,183)
Accretion of discount on Series B and B1	(223,727)	$ (223,727)	$ 0									(223,727)
Accretion of redeemable non-controlling interest to redemption value	(373,748)											(373,748)
Net income (loss)	2,965,338											974,369	1,990,969
Less: amount attributable to redeemable non-controlling interest	(1,542,402)												(1,542,402)
Ending balance at Mar. 31, 2021	$ 19,268,266			$ 51,742			$ 420	$ 0	$ 106,823,405			$ (89,373,746)	$ 1,766,445
Ending balance (in shares) at Mar. 31, 2021				51,742,499			419,859	0